Phosphotyrosine profiling identifies the KG-1 cell line as a model for the study of FGFR1 fusions in acute myeloid leukemia

被引:68
作者
Gu, Ting-Lei
Goss, Valerie L.
Reeves, Cynthia
Popova, Lana
Nardone, Julie
MacNeill, Joan
Walters, Denise K.
Wang, Yi
Rush, John
Comb, Michael J.
Druker, Brian J.
Polakiewicz, Roberto D.
机构
[1] Cell Signaling Technol Inc, Danvers, MA 01923 USA
[2] Oregon Hlth Sci Univ, Inst Canc, Howard Hughes Med Inst, Dept Hematol & Oncol, Portland, OR 97201 USA
关键词
D O I
10.1182/blood-2006-06-026666
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The 8p11 myeloproliferative syndrome (EMS) is associated with translocations that disrupt the FGFR1 gene. To date, 8 fusion partners of FGFR1 have been identified. However, no primary leukemia cell lines were identified that contain any of these fusions. Here, we screened more than 40 acute myelold leukemia cell lines for constitutive phosphorylation of STAT5 and applied an immunoaffinity profiling strategy to identify tyrosine-phosphorylated proteins in the KG-1 cell line. Mass spectrometry analysis of KG-1 cells revealed aberrant tyrosine phosphorylation of FGFR1. Subsequent analysis led to the identification of a fusion of the FGFR1OP2 gene to the FGFR1 gene. Small interfering RNA (siRNA) against FGFR1 specifically inhibited the growth and induced apoptosis of KG-1 cells. Thus, the KG-1 cell line provides an in vitro model for the study of FGFR1 fusions associated with leukemia and for the analysis of small molecule inhibitors against FGFR1 fusions.
引用
收藏
页码:4202 / 4204
页数:3
相关论文
共 23 条
[1]   8pII myeloproliferative syndrome with a novel t(7;8) translocation leading to fusion of the FGFRI and TIFI genes [J].
Belloni, E ;
Trubia, M ;
Gasparini, P ;
Micucci, C ;
Tapinassi, C ;
Confalonieri, S ;
Nuciforo, P ;
Martino, B ;
Lo-Coco, F ;
Pelicci, PG ;
Di Fiore, PP .
GENES CHROMOSOMES & CANCER, 2005, 42 (03) :320-325
[2]   PKC412 inhibits the zinc finger 198-fibroblast growth factor receptor 1 fusion tyrosine kinase and is active in treatment of stem cell myeloproliferative disorder [J].
Chen, J ;
DeAngelo, DJ ;
Kutok, JL ;
Williams, IR ;
Lee, BH ;
Wadleigh, M ;
Duclos, N ;
Cohen, S ;
Adelsperger, J ;
Okabe, R ;
Coburn, A ;
Galinsky, I ;
Huntly, B ;
Cohen, PS ;
Meyer, T ;
Fabbro, D ;
Roesel, J ;
Banerji, L ;
Griffin, JD ;
Xiao, S ;
Fletcher, JA ;
Stone, RM ;
Gilliland, DG .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2004, 101 (40) :14479-14484
[3]   The t(8;22) in chronic myeloid leukemia fuses BCR to FGFR1: transforming activity and specific inhibition of FGFR1 fusion proteins [J].
Demiroglu, A ;
Steer, EJ ;
Heath, C ;
Taylor, K ;
Bentley, M ;
Allen, SL ;
Koduru, P ;
Brody, JP ;
Hawson, G ;
Rodwell, R ;
Doody, ML ;
Carnicero, F ;
Reiter, A ;
Goldman, JM ;
Melo, JV ;
Cross, NCP .
BLOOD, 2001, 98 (13) :3778-3783
[4]   Identification of a novel gene, FGFR1OP2, fused to FGFR1 in 8p11 myeloproliferative syndrome [J].
Grand, EK ;
Grand, FH ;
Chase, AJ ;
Ross, FM ;
Corcoran, MM ;
Oscier, DG ;
Cross, NCP .
GENES CHROMOSOMES & CANCER, 2004, 40 (01) :78-83
[5]   FGFR1 is fused to the centrosome-associated protein CEP110 in the 8p12 stem cell myeloproliferative disorder with t(8;9)(p12;q33) [J].
Guasch, G ;
Mack, GJ ;
Popovici, C ;
Dastugue, N ;
Birnbaum, D ;
Rattner, JB ;
Pébusque, MJ .
BLOOD, 2000, 95 (05) :1788-1796
[6]   FOP-FGFR1 tyrosine kinase, the product of a t(6;8) translocation, induces a fatal myeloproliferative disease in mice [J].
Guasch, G ;
Delaval, B ;
Arnoulet, C ;
Xie, MJ ;
Xerri, L ;
Sainty, D ;
Birnbaum, D ;
Pébusque, MJ .
BLOOD, 2004, 103 (01) :309-312
[7]   Endogenous retroviral sequence is fused to FGFR1 kinase in the 8p12 stem-cell myeloproliferative disorder with t(8;19)(p12;q13.3) [J].
Guasch, G ;
Popovici, C ;
Mugneret, F ;
Chaffanet, M ;
Pontarotti, P ;
Birnbaum, D ;
Pébusque, MJ .
BLOOD, 2003, 101 (01) :286-288
[8]   8p12 stem cell myeloproliferative disorder:: the FOP-fibroblast growth factor receptor 1 fusion protein of the t(6;8) translocation induces cell survival mediated by mitogen-activated protein kinase and phosphatidylinositol 3-kinase/Akt/mTOR pathways [J].
Guasch, G ;
Ollendorff, V ;
Borg, JP ;
Birnbaum, D ;
Pébusque, MJ .
MOLECULAR AND CELLULAR BIOLOGY, 2001, 21 (23) :8129-8142
[9]   Critical role of STAT5 activation in transformation mediated by ZNF198-FGFR1 [J].
Heath, C ;
Cross, NCP .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2004, 279 (08) :6666-6673
[10]   A SYNDROME OF LYMPHOBLASTIC LYMPHOMA, EOSINOPHILIA, AND MYELOID HYPERPLASIA MALIGNANCY ASSOCIATED WITH T(8-13) (P11-Q11) - DESCRIPTION OF A DISTINCTIVE CLINICOPATHOLOGICAL ENTITY [J].
INHORN, RC ;
ASTER, JC ;
ROACH, SA ;
SLAPAK, CA ;
SOIFFER, R ;
TANTRAVAHI, R ;
STONE, RM .
BLOOD, 1995, 85 (07) :1881-1887